LICHEN PLANOPILARIS
Clinical trials for LICHEN PLANOPILARIS explained in plain language.
Never miss a new study
Get alerted when new LICHEN PLANOPILARIS trials appear
Sign up with your email to follow new studies for LICHEN PLANOPILARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cream stop scarring hair loss? small trial begins
Disease control Recruiting nowThis pilot study tests a topical cream called delgocitinib in 30 adults with two types of scarring hair loss: lichen planopilaris and central centrifugal cicatricial alopecia. Participants apply the cream twice daily for 48 weeks. The study focuses on safety and changes in immune…
Matched conditions: LICHEN PLANOPILARIS
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New pill could stop scalp scarring and hair loss
Disease control Recruiting nowThis study tests an oral medication called brepocitinib for adults with lichen planopilaris, a condition that causes scalp inflammation, scarring, and hair loss. About 342 participants will receive either the drug or a placebo to see if it reduces symptoms and improves scalp appe…
Matched conditions: LICHEN PLANOPILARIS
Phase: PHASE2, PHASE3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC